Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Diabetes

Patients diagnosed with type 2 diabetes to be put on 800-calorie diet in new NHS pilot

Previous study found that 46% of type 2 diabetes patients went into remission following low-calorie weight management. 

Diabetic woman eating soup

Source: Shutterstock.com

Participants in an NHS England pilot scheme will be put on a 800-calorie liquid diet of soups and shakes

People diagnosed with type 2 diabetes will be placed on a low-calorie diet as part of a new pilot scheme to treat the condition, NHS England has announced.

The pilot, which will start in 2019, will follow 5,000 patients prescribed a liquid diet of just over 800 calories per day for three months in an effort to send their type 2 diabetes into remission.

A statement from NHS England said the pilot follows on from a study of 306 people funded by Diabetes UK, which found that 46% of patients on the low-calorie diet achieved remission of their type 2 diabetes after one year. Among patients in the control group, who were provided current standard of diabetes care but without low-calorie weight management, only 4% were in remission a year later. 

Patients taking part in the new NHS England pilot will also be provided with a period of follow-up support after the diet had finished.

Jonathan Valabhji, national clinical director of diabetes and obesity for NHS England, said: “Around two-thirds of adults and one third of children are now overweight or obese, driving higher and higher rates of type 2 diabetes that we are now focusing huge efforts to address.

“Our work so far in this area has been producing really positive results and todays announcement will allow us to go even further — it will help patients who have type 2 diabetes to achieve remission and, importantly, help more of those who are at risk to not get it in the first place.”

Simon Stevens, chief executive of NHS England, added that the initiative will also save money, “given the huge costs to all of us as taxpayers from these largely preventable illnesses”.

According to NHS England, type 2 diabetes treatment accounts for £8.8bn per year — just under 9% of the annual NHS budget.

The pilot will form part of the NHS Diabetes Prevention Programme, which aims to support people who are at high risk of developing type 2 diabetes through a tailored face-to-face programme that includes education on lifestyle choices, advice on how to reduce weight through healthier eating and bespoke physical activity programmes.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205833

Readers' comments (1)

  • Isn't this pilot only including patients who have an established diagnosis of type 2 diabetes and looking at whether or not they go into remission? It appears the original study did so. How can the announcement therefore "importantly, help more of those who are at risk to not get it in the first place" when that's not what is being studied? It would seem like a logical extrapolation, but wouldn't a separate study be required to specifically look at prevention?

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Diabetic woman eating soup

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.